The involvement of neuropeptides in evolution, signaling, behavioral regulation and psychopathology: focus on vasopressin
Authors:
- 1 August 2005
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 65 (4) , 185-190
Abstract
This brief commentary focuses on the involvement of neuropeptides in a variety of brain functions. As exemplified with vasopressin, neuropeptides are released within distinct brain areas to contribute to regionally and temporally varying modes of neuromodulator and neurotransmitter actions, thus providing a theoretically unlimited variability in interneuronal signaling. As primary products of protein biosynthesis, neuropeptides and their receptors are critical substrates for the evolution of behavior, including emotionality. Particularly its capability of responding to stressful stimuli and mediating genetic polymorphisms make the central release of vasopressin a key process for converging (i.e., environmentally and genetically driven) behavioral regulation. This release along a continuum from basal to very high levels in the extracellular fluid of distinct brain areas explains the wide spectrum of vasopressin effects in the brain, including its role in psychopathology. Drug Dev. Res. 65:185–190, 2005.Keywords
This publication has 25 references indexed in Scilit:
- Microsatellite Instability Generates Diversity in Brain and Sociobehavioral TraitsScience, 2005
- Stress and the brain: from adaptation to diseaseNature Reviews Neuroscience, 2005
- Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related DisordersCurrent Pharmaceutical Design, 2005
- The hypothalamic–neurohypophysial system regulates the hypothalamic–pituitary–adrenal axis under stress: An old concept revisitedFrontiers in Neuroendocrinology, 2004
- Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin V1a Receptor Knockout MiceNeuropsychopharmacology, 2003
- Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersTrends in Pharmacological Sciences, 2003
- Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat ModelNeuropsychopharmacology, 2002
- Evolution of vertebrate neuropeptidesBrain Research Bulletin, 2001
- Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in ratsEuropean Journal of Neuroscience, 1999
- Behavioral Consequences of Intracerebral Vasopressin and Oxytocin: Focus on Learning and Memory **This paper is dedicated to our friend and scientific teacher Prof. Dr Armin Ermisch (1935–1995).Neuroscience & Biobehavioral Reviews, 1996